Please provide your email address to receive an email when new articles are posted on . Use of budesonide before FMT did not increase donor microbiota engraftment or clinical response. Differences in ...
Please provide your email address to receive an email when new articles are posted on . BATURA showed a 47% reduction in severe exacerbation risk with albuterol budesonide vs. albuterol in patients ...
Severe exacerbation occurred in 5.1% of patients taking albuterol/budesonide compared with 9.1% of patients taking albuterol alone in the on-treatment efficacy population. Albuterol/budesonide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results